Wells Fargo & Company Sc Pharmaceuticals Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 9,091 shares of SCPH stock, worth $46,455. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,091

Previous 8,588 5.86%

Holding current value

$46,455

Previous $43,000 9.3%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$3.51 - $5.21 $1,765 - $2,620	503 Added 5.86%	9,091 $39,000
Q1 2024 May 10, 2024	BUY	$4.86 - $6.39 $5,608 - $7,374	1,154 Added 15.52%	8,588 $43,000
Q4 2023 Feb 09, 2024	BUY	$4.7 - $6.63 $7,985 - $11,264	1,699 Added 29.63%	7,434 $46,000
Q3 2023 Nov 13, 2023	SELL	$7.0 - $9.82 $43,638 - $61,217	-6,234 Reduced 52.08%	5,735 $40,000
Q2 2023 Aug 15, 2023	BUY	$8.94 - $11.74 $105,992 - $139,189	11,856 Added 10492.04%	11,969 $121,000
Q1 2023 May 12, 2023	BUY	$5.59 - $9.47 $268 - $454	48 Added 73.85%	113 $1,000
Q4 2022 Feb 13, 2023	BUY	$4.02 - $7.53 $4 - $7	1 Added 1.56%	65 $0
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.52 $8 - $13	-2 Reduced 3.03%	64 $0
Q2 2022 Aug 12, 2022	BUY	$4.3 - $6.48 $21 - $32	5 Added 8.2%	66 $0
Q1 2022 May 16, 2022	BUY	$3.9 - $6.11 $3 - $6	1 Added 1.67%	61 $0
Q2 2021 Aug 16, 2021	SELL	$5.19 - $7.38 $11,085 - $15,763	-2,136 Reduced 97.27%	60 $0
Q1 2021 May 13, 2021	SELL	$5.65 - $7.66 $100,479 - $136,225	-17,784 Reduced 89.01%	2,196 $15,000
Q4 2020 Feb 09, 2021	BUY	$5.17 - $9.41 $19,325 - $35,174	3,738 Added 23.01%	19,980 $105,000
Q3 2020 Nov 05, 2020	BUY	$7.12 - $8.86 $11,712 - $14,574	1,645 Added 11.27%	16,242 $121,000
Q2 2020 Aug 13, 2020	BUY	$7.01 - $10.96 $102,177 - $159,752	14,576 Added 69409.52%	14,597 $108,000
Q1 2020 May 14, 2020	BUY	$5.4 - $10.45 $113 - $219	21 New	21 $0

Others Institutions Holding SCPH

# of Institutions

Shares Held

27.7M

Call Options Held

39.2K

Put Options Held

2.6K

View Full List

About scPharmaceuticals Inc.

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $140M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

More about SCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Sc Pharmaceuticals Inc. Transaction History